Literature DB >> 18493017

Focal adhesion kinase versus p53: apoptosis or survival?

William G Cance1, Vita M Golubovskaya.   

Abstract

Focal adhesion kinase (FAK) is a tyrosine kinase that interacts with a multitude of signaling partners and helps cells to survive in the face of various proapoptotic signals. One of the most important interactions for FAK is with the tumor suppressor protein p53. p53 binds not only to the amino-terminal domain of FAK but also to the FAK promoter to inhibit its transcription. A study now reports the biological implications of the kinase-independent interaction of FAK with p53, which opens up future perspectives in cell signaling and cancer research. We focus on FAK and p53 signaling, which link signal transduction pathways from the extracellular matrix and cytoplasm to the nucleus, in human and mouse cells. FAK is proposed to be a critical scaffold protein that sequesters proapoptotic proteins, such as p53, to mediate cell survival.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18493017      PMCID: PMC4560103          DOI: 10.1126/stke.120pe22

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  28 in total

1.  Focal adhesion kinase as a marker of invasive potential in differentiated human thyroid cancer.

Authors:  L V Owens; L Xu; G A Dent; X Yang; G C Sturge; R J Craven; W G Cance
Journal:  Ann Surg Oncol       Date:  1996-01       Impact factor: 5.344

2.  Direct interaction of focal adhesion kinase (FAK) with Met is required for FAK to promote hepatocyte growth factor-induced cell invasion.

Authors:  Shu-Yi Chen; Hong-Chen Chen
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

3.  Upregulation of focal adhesion kinase (FAK) expression in ductal carcinoma in situ (DCIS) is an early event in breast tumorigenesis.

Authors:  Harry M Lightfoot; Amy Lark; Chad A Livasy; Dominic T Moore; David Cowan; Lynn Dressler; Rolf J Craven; William G Cance
Journal:  Breast Cancer Res Treat       Date:  2004-11       Impact factor: 4.872

4.  The death domain kinase RIP mediates the TNF-induced NF-kappaB signal.

Authors:  M A Kelliher; S Grimm; Y Ishida; F Kuo; B Z Stanger; P Leder
Journal:  Immunity       Date:  1998-03       Impact factor: 31.745

5.  p53 regulates FAK expression in human tumor cells.

Authors:  Vita M Golubovskaya; Richard Finch; Frederick Kweh; Nicole A Massoll; Martha Campbell-Thompson; Margaret R Wallace; William G Cance
Journal:  Mol Carcinog       Date:  2008-05       Impact factor: 4.784

6.  Expression of focal adhesion kinase gene and invasive cancer.

Authors:  T M Weiner; E T Liu; R J Craven; W G Cance
Journal:  Lancet       Date:  1993-10-23       Impact factor: 79.321

7.  Focal adhesion kinase suppresses apoptosis by binding to the death domain of receptor-interacting protein.

Authors:  Elena Kurenova; Li-Hui Xu; Xihui Yang; Albert S Baldwin; Rolf J Craven; Steven K Hanks; Zheng-Gang Liu; William G Cance
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

8.  Cloning and characterization of the promoter region of human focal adhesion kinase gene: nuclear factor kappa B and p53 binding sites.

Authors:  Vita Golubovskaya; Aparna Kaur; William Cance
Journal:  Biochim Biophys Acta       Date:  2004-05-25

9.  Cytoplasmic p53: bax and forward.

Authors:  Jerry E Chipuk; Douglas R Green
Journal:  Cell Cycle       Date:  2004-04-01       Impact factor: 4.534

10.  Focal adhesion kinase N-terminus in breast carcinoma cells induces rounding, detachment and apoptosis.

Authors:  Lucia Beviglia; Vita Golubovskaya; LiHui Xu; XiHui Yang; Rolf J Craven; William G Cance
Journal:  Biochem J       Date:  2003-07-01       Impact factor: 3.857

View more
  48 in total

1.  A small molecule focal adhesion kinase (FAK) inhibitor, targeting Y397 site: 1-(2-hydroxyethyl)-3, 5, 7-triaza-1-azoniatricyclo [3.3.1.1(3,7)]decane; bromide effectively inhibits FAK autophosphorylation activity and decreases cancer cell viability, clonogenicity and tumor growth in vivo.

Authors:  Vita M Golubovskaya; Sheila Figel; Baotran T Ho; Christopher P Johnson; Michael Yemma; Grace Huang; Min Zheng; Carl Nyberg; Andrew Magis; David A Ostrov; Irwin H Gelman; William G Cance
Journal:  Carcinogenesis       Date:  2012-03-07       Impact factor: 4.944

2.  Dentin phosphoprotein (DPP) activates integrin-mediated anchorage-dependent signals in undifferentiated mesenchymal cells.

Authors:  Asha Eapen; Amsaveni Ramachandran; Anne George
Journal:  J Biol Chem       Date:  2011-12-01       Impact factor: 5.157

3.  Nanog increases focal adhesion kinase (FAK) promoter activity and expression and directly binds to FAK protein to be phosphorylated.

Authors:  Baotran Ho; Gretchen Olson; Sheila Figel; Irwin Gelman; William G Cance; Vita M Golubovskaya
Journal:  J Biol Chem       Date:  2012-04-05       Impact factor: 5.157

4.  Focal adhesion kinase can play unique and opposing roles in regulating the morphology of differentiating oligodendrocytes.

Authors:  Audrey D Lafrenaye; Babette Fuss
Journal:  J Neurochem       Date:  2010-08-19       Impact factor: 5.372

Review 5.  Targeting the p53 pathway.

Authors:  Vita M Golubovskaya; William G Cance
Journal:  Surg Oncol Clin N Am       Date:  2013-07-30       Impact factor: 3.495

6.  From tumorigenesis to microenvironment and immunoregulation: the many faces of focal adhesion kinase and challenges associated with targeting this elusive protein.

Authors:  Felicia L Lenzo; William G Cance
Journal:  Transl Cancer Res       Date:  2017-08       Impact factor: 1.241

Review 7.  FAK in cancer: mechanistic findings and clinical applications.

Authors:  Florian J Sulzmaier; Christine Jean; David D Schlaepfer
Journal:  Nat Rev Cancer       Date:  2014-08-07       Impact factor: 60.716

8.  Autophosphorylation-independent and -dependent functions of focal adhesion kinase during development.

Authors:  Jean-Marc Corsi; Christophe Houbron; Pierre Billuart; Isabelle Brunet; Karine Bouvrée; Anne Eichmann; Jean-Antoine Girault; Hervé Enslen
Journal:  J Biol Chem       Date:  2009-09-23       Impact factor: 5.157

Review 9.  Disrupting the scaffold to improve focal adhesion kinase-targeted cancer therapeutics.

Authors:  William G Cance; Elena Kurenova; Timothy Marlowe; Vita Golubovskaya
Journal:  Sci Signal       Date:  2013-03-26       Impact factor: 8.192

10.  Pharmacologic blockade of FAK autophosphorylation decreases human glioblastoma tumor growth and synergizes with temozolomide.

Authors:  Vita M Golubovskaya; Grace Huang; Baotran Ho; Michael Yemma; Carl D Morrison; Jisook Lee; Brian P Eliceiri; William G Cance
Journal:  Mol Cancer Ther       Date:  2012-12-12       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.